Silence Therapeutics PLC (SLN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.23B
Last updated: Nov 17, 2026 at 4:15 PM ET
Silence Therapeutics PLC (SLN) Stock Chart
Silence Therapeutics (SLN) has a latest price of $19.80 on Nov 17, 2026, 0.3% below its 52-week high of $19.86. Its price rose 189.9% over the past 12 months. The month-end price fell 10.2% over the 5 years through Oct 2026, a compound annual decline of 2.1%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $27.46 in May 2021 and its lowest $2.82 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SLN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SLN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 45.5%, and over 6 months it rose 243.2%. The month-end price rose 194.8% over the 3 years through Oct 2026, a compound annual rate of 43.4%.
| Period | Change |
|---|---|
| 1 month | +1.1% |
| 3 months | +45.5% |
| 6 months | +243.2% |
| 12 months | +189.9% |
| 12 months, with dividends | +189.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +194.8% | +43.4% |
| 5 years | -10.2% | -2.1% |
Price by Year
Its best calendar year was 2023, when the price rose 13.9%, and its weakest was 2024, when it fell 60.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $19.75 | +224.8% |
| 2025 | $6.08 | -11.6% |
| 2024 | $6.88 | -60.4% |
| 2023 | $17.37 | +13.9% |
| 2022 | $15.25 | -36.2% |
| 2021 | $23.89 | +8.6% |
Trading Range
The price is 33.0% above its 50-day average of $14.89 and 99.5% above its 200-day average of $9.93.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $19.80 | |
| 52-week high | $19.86 | -0.3% |
| 52-week low | $4.19 | +372.6% |
| 50-day average | $14.89 | +33.0% |
| 200-day average | $9.93 | +99.5% |
Price Risk
Over 3 years, its largest fall from a peak was 91.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.44 |
| Largest fall, 1 year | -43.7% |
| Largest fall, 3 years | -91.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SLN
What is SLN's 1-year price change?
Silence Therapeutics's price rose 189.9% over the past 12 months. With dividends included, the 12-month total return was 189.9%.
What is SLN's 5-year price change?
Silence Therapeutics's month-end price fell 10.2% over the 5 years through Oct 2026, a compound annual decline of 2.1%. These figures leave out dividends.
What is SLN's 52-week high and low?
Silence Therapeutics's 52-week high is $19.86 and its 52-week low is $4.19. Its latest price of $19.80 on Nov 17, 2026 is 0.3% below the high.
What is SLN's beta?
Silence Therapeutics's 1-year beta against the S&P 500 is 1.44, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 43.7%.
Is the SLN chart free?
Yes. Advanced Charting for SLN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SLN pages: Overview, Charting, Statistics, Valuation, Competitors